| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
93 |
45 |
$24K |
| J7999 |
Compounded drug, not otherwise classified |
593 |
299 |
$17K |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
95 |
44 |
$634.14 |
| S9328 |
Home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
26 |
25 |
$0.00 |